Organization Profile

You just read:

Quest PharmaTech Updates Progress of Phase II Oregovomab Front-Line Chemo-Immunotherapy Clinical Trial in Italy

News provided by

Quest PharmaTech Inc.

Jul 10, 2012, 09:30 ET